Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.54 CNY -1.95% Market Closed
Market Cap: 4.6B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Hunan Fangsheng Pharmaceutical Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hunan Fangsheng Pharmaceutical Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Accrued Liabilities
ÂĄ42.4m
CAGR 3-Years
16%
CAGR 5-Years
31%
CAGR 10-Years
37%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accrued Liabilities
ÂĄ2B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accrued Liabilities
ÂĄ620.1m
CAGR 3-Years
74%
CAGR 5-Years
53%
CAGR 10-Years
31%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accrued Liabilities
ÂĄ128.5m
CAGR 3-Years
456%
CAGR 5-Years
130%
CAGR 10-Years
63%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accrued Liabilities
ÂĄ1.5B
CAGR 3-Years
74%
CAGR 5-Years
54%
CAGR 10-Years
46%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accrued Liabilities
ÂĄ146m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.6B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Hunan Fangsheng Pharmaceutical Co Ltd's Accrued Liabilities?
Accrued Liabilities
42.4m CNY

Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Accrued Liabilities amounts to 42.4m CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
37%

Over the last year, the Accrued Liabilities growth was 118%. The average annual Accrued Liabilities growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 16% over the past three years , 31% over the past five years , and 37% over the past ten years .

Back to Top